A detailed history of Marco Investment Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Marco Investment Management LLC holds 39,277 shares of AMGN stock, worth $11.2 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
39,277
Previous 39,052 0.58%
Holding current value
$11.2 Million
Previous $12.2 Million 3.72%
% of portfolio
1.1%
Previous 1.13%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $69,610 - $75,910
225 Added 0.58%
39,277 $12.7 Million
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $111,406 - $135,387
-424 Reduced 1.07%
39,052 $12.2 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $905,285 - $1.09 Million
3,367 Added 9.32%
39,476 $11.2 Million
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $590,667 - $666,342
-2,310 Reduced 6.01%
36,109 $10.4 Million
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $831,963 - $1.03 Million
-3,805 Reduced 9.01%
38,419 $10.3 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $97,278 - $115,029
-454 Reduced 1.06%
42,224 $9.37 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $192,824 - $235,020
-854 Reduced 1.96%
42,678 $10.3 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $99,399 - $126,298
-434 Reduced 0.99%
43,532 $11.4 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $190,566 - $214,924
-849 Reduced 1.89%
43,966 $9.91 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $190,566 - $214,924
-849 Reduced 1.89%
43,966 $9.91 Million
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $57,446 - $63,928
-249 Reduced 0.55%
44,815 $10.9 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $125,641 - $138,992
-573 Reduced 1.26%
45,064 $10.9 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $3.58 Million - $4.09 Million
-17,989 Reduced 28.27%
45,637 $10.3 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $607,092 - $711,282
2,860 Added 4.71%
63,626 $13.5 Million
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $128,235 - $142,267
-549 Reduced 0.9%
60,766 $14.8 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $27,516 - $32,066
-124 Reduced 0.2%
61,315 $15.3 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $3.3 Million - $3.93 Million
15,241 Added 32.99%
61,439 $14.1 Million
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $191,239 - $212,674
-815 Reduced 1.73%
46,198 $11.7 Million
Q2 2020

Jul 21, 2020

SELL
$197.81 - $242.74 $390,674 - $479,411
-1,975 Reduced 4.03%
47,013 $11.1 Million
Q1 2020

Apr 17, 2020

SELL
$182.24 - $241.7 $3.73 Million - $4.95 Million
-20,488 Reduced 29.49%
48,988 $9.93 Million
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $291,383 - $374,528
-1,540 Reduced 2.17%
69,476 $16.7 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $74,867 - $89,706
430 Added 0.61%
71,016 $13.7 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $33,340 - $39,082
-200 Reduced 0.28%
70,586 $13 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $2.06 Million - $2.32 Million
-11,365 Reduced 13.83%
70,786 $13.4 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $4.19 Million - $4.9 Million
-23,514 Reduced 22.25%
82,151 $16 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $2.4 Million - $2.7 Million
-12,936 Reduced 10.91%
105,665 $21.9 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $874,253 - $981,975
5,265 Added 4.65%
118,601 $21.9 Million
Q1 2018

May 01, 2018

SELL
$169.43 - $198.0 $107,249 - $125,334
-633 Reduced 0.56%
113,336 $19.3 Million
Q4 2017

Feb 15, 2018

BUY
$168.79 - $188.59 $18.2 Million - $20.3 Million
107,880 Added 1771.72%
113,969 $19.8 Million
Q3 2017

Nov 15, 2017

SELL
$167.29 - $191.0 $18.4 Million - $21 Million
-110,000 Reduced 94.75%
6,089 $21.6 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $125,467 - $143,250
-750 Reduced 0.64%
116,089 $21.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
116,839
116,839 $20.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.